CME Group Inc (CME) Shares Bought by Calamos Advisors LLC

Share on StockTwits

Calamos Advisors LLC lifted its stake in shares of CME Group Inc (NASDAQ:CME) by 1.0% in the first quarter, according to its most recent filing with the SEC. The fund owned 36,824 shares of the financial services provider’s stock after acquiring an additional 368 shares during the period. Calamos Advisors LLC’s holdings in CME Group were worth $6,060,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Sheaff Brock Investment Advisors LLC increased its position in shares of CME Group by 0.3% in the fourth quarter. Sheaff Brock Investment Advisors LLC now owns 22,040 shares of the financial services provider’s stock valued at $4,146,000 after acquiring an additional 60 shares during the period. Dorsey & Whitney Trust CO LLC increased its position in shares of CME Group by 1.4% in the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 4,575 shares of the financial services provider’s stock valued at $860,000 after acquiring an additional 65 shares during the period. Private Trust Co. NA increased its position in shares of CME Group by 1.9% in the fourth quarter. Private Trust Co. NA now owns 3,488 shares of the financial services provider’s stock valued at $656,000 after acquiring an additional 66 shares during the period. Dubuque Bank & Trust Co. increased its position in shares of CME Group by 83.1% in the first quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 69 shares during the period. Finally, Front Barnett Associates LLC increased its position in shares of CME Group by 5.4% in the fourth quarter. Front Barnett Associates LLC now owns 1,433 shares of the financial services provider’s stock valued at $267,000 after acquiring an additional 73 shares during the period. 84.85% of the stock is owned by institutional investors.

In related news, Director Jeffrey M. Bernacchi sold 10,087 shares of the business’s stock in a transaction dated Tuesday, February 26th. The shares were sold at an average price of $177.94, for a total transaction of $1,794,880.78. Following the sale, the director now owns 42,004 shares of the company’s stock, valued at $7,474,191.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction dated Wednesday, April 3rd. The stock was sold at an average price of $168.27, for a total transaction of $420,675.00. Following the sale, the chief financial officer now directly owns 35,354 shares in the company, valued at approximately $5,949,017.58. The disclosure for this sale can be found here. Insiders have sold 28,489 shares of company stock worth $4,948,996 in the last quarter. 1.20% of the stock is owned by corporate insiders.

Shares of NASDAQ CME opened at $172.92 on Friday. CME Group Inc has a 1 year low of $153.90 and a 1 year high of $197.08. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.01 and a current ratio of 1.01. The stock has a market cap of $61.02 billion, a P/E ratio of 25.35, a P/E/G ratio of 3.48 and a beta of 0.29.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, February 14th. The financial services provider reported $1.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.02. CME Group had a net margin of 45.53% and a return on equity of 9.85%. The company had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.22 billion. During the same quarter in the previous year, the company earned $1.12 earnings per share. CME Group’s quarterly revenue was up 37.4% on a year-over-year basis. As a group, equities analysts predict that CME Group Inc will post 6.82 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Monday, March 25th. Investors of record on Friday, March 8th were given a dividend of $0.75 per share. The ex-dividend date was Thursday, March 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.73%. This is a boost from CME Group’s previous quarterly dividend of $0.70. CME Group’s payout ratio is currently 43.99%.

A number of equities analysts have issued reports on the stock. Citigroup set a $205.00 price objective on shares of CME Group and gave the company a “buy” rating in a research report on Friday, February 15th. BidaskClub cut shares of CME Group from a “buy” rating to a “hold” rating in a research report on Thursday, January 31st. JPMorgan Chase & Co. assumed coverage on shares of CME Group in a research report on Friday, February 15th. They issued an “underweight” rating and a $164.00 price objective on the stock. ValuEngine cut shares of CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 20th. Finally, Deutsche Bank decreased their price objective on shares of CME Group from $220.00 to $214.00 and set a “buy” rating on the stock in a research report on Friday, March 15th. Three analysts have rated the stock with a sell rating, eight have given a hold rating and six have issued a buy rating to the company’s stock. CME Group presently has a consensus rating of “Hold” and an average target price of $192.00.

ILLEGAL ACTIVITY WARNING: “CME Group Inc (CME) Shares Bought by Calamos Advisors LLC” was first reported by Highlight Press and is owned by of Highlight Press. If you are reading this report on another publication, it was stolen and reposted in violation of US and international copyright & trademark laws. The original version of this report can be viewed at https://highlightpress.com/2019/04/14/cme-group-inc-cme-shares-bought-by-calamos-advisors-llc.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: Fundamental Analysis

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.